Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Mazer

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Critical Care Medicine|December 22, 2009
Addition of rifampin to vancomycin for the treatment of pneumonias due to methicillin-resistant Staphylococcus aureus: caveat emptorKeith M Ramsey, Mark A Mazer
Intensive Care Medicine|January 21, 2014
Expanding the pool of healthcare providers to perform penicillin skin testing in the ICURamzy H Rimawi, Mark A Mazer
Southern Medical Journal|June 30, 2009
Pancreatic pseudocyst rupture into the portal veinBrian C Dawson, David Kasa, Mark A Mazer
Journal of Pain and Symptom Management|January 15, 2011
The infusion of opioids during terminal withdrawal of mechanical ventilation in the medical intensive care unitMark A Mazer, Chad M Alligood, Qiang Wu
The Annals of Pharmacotherapy|August 19, 2003
Severe hypersensitivity pneumonitis associated with anagrelideMurugan Raghavan, Mark A Mazer, David J Brink
Critical Care Medicine|November 1, 2006
The public's attitude and perception concerning witnessed cardiopulmonary resuscitationMark A Mazer, Lori A Cox, J Anthony Capon
Critical Care Medicine|March 18, 2014
The authors replyRamzy H Rimawi, Paul P Cook, Mark A Mazer
ATS Scholar|August 19, 2021
Teaching Deliberation and Restraint in Interpreting a Tempest of COVID-19 "Information"Adrien J Mazer, Mark A Mazer, Barry R Meisenberg
Infection|July 21, 2017
Can a collaborative subspecialty antimicrobial stewardship intervention have lasting effects?Kaushal B Shah, Ramzy H Rimawi, Mark A Mazer, et al.
Critical Care Medicine|July 23, 2013
Impact of regular collaboration between infectious diseases and critical care practitioners on antimicrobial utilization and patient outcomeRamzy H Rimawi, Mark A Mazer, Dawd S Siraj, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Critical Care Medicine|December 22, 2009
Addition of rifampin to vancomycin for the treatment of pneumonias due to methicillin-resistant Staphylococcus aureus: caveat emptorKeith M Ramsey, Mark A Mazer
Intensive Care Medicine|January 21, 2014
Expanding the pool of healthcare providers to perform penicillin skin testing in the ICURamzy H Rimawi, Mark A Mazer
Southern Medical Journal|June 30, 2009
Pancreatic pseudocyst rupture into the portal veinBrian C Dawson, David Kasa, Mark A Mazer
Journal of Pain and Symptom Management|January 15, 2011
The infusion of opioids during terminal withdrawal of mechanical ventilation in the medical intensive care unitMark A Mazer, Chad M Alligood, Qiang Wu
The Annals of Pharmacotherapy|August 19, 2003
Severe hypersensitivity pneumonitis associated with anagrelideMurugan Raghavan, Mark A Mazer, David J Brink
Critical Care Medicine|November 1, 2006
The public's attitude and perception concerning witnessed cardiopulmonary resuscitationMark A Mazer, Lori A Cox, J Anthony Capon
Critical Care Medicine|March 18, 2014
The authors replyRamzy H Rimawi, Paul P Cook, Mark A Mazer
ATS Scholar|August 19, 2021
Teaching Deliberation and Restraint in Interpreting a Tempest of COVID-19 "Information"Adrien J Mazer, Mark A Mazer, Barry R Meisenberg
Infection|July 21, 2017
Can a collaborative subspecialty antimicrobial stewardship intervention have lasting effects?Kaushal B Shah, Ramzy H Rimawi, Mark A Mazer, et al.
Critical Care Medicine|July 23, 2013
Impact of regular collaboration between infectious diseases and critical care practitioners on antimicrobial utilization and patient outcomeRamzy H Rimawi, Mark A Mazer, Dawd S Siraj, et al.
Pageof 2